Cancer Detection

GLP-1 Drugs Tied to Atypical PET-CT Patterns That Could Mislead Cancer Imaging, Study Finds

Investigators say drug-driven glucose shifts can mimic disease on FDG-PET, prompting radiology teams to flag GLP-1 use during reads.